OLD Category: Oncology

Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer

• Doo DW et al.,

Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation

• Chen M et al.,

Zebrafish B cell acute lymphoblastic leukemia: new findings in an old model

• Park G et al.,

Underlying Ossification Phenotype in a Murine Model of Metastatic Synovial Sarcoma

• Kirkham M et al.,

Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer

• Yu JI et al.,

Changing Technologies of RNA Sequencing and Their Applications in Clinical Oncology

• Wang Y, Mashock M, Tong Z, Mu X, Chen H, Zhou X, Zhang H, Zhao G, Liu B, Li X

Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study

• Gonzalez-Cao M et al.,

LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma

• Keane C, Law SC, Gould C, Birch S, Sabdia MB, Merida de Long L, Thillaiyampalam G, Abro E, Tobin JW, Tan X, Xu-Monette ZY, Young KH, Gifford G, Gabreilli S, Stevenson WS, Gill A, Talaulikar D, Jain S, Hernandez A, Halliday SJ, Bird R, Cross D, Hertzberg M, Gandhi MK

Early hepatic lesions display immature tertiary lymphoid structures and show elevated expression of immune inhibitory and immunosuppressive molecules

• Meylan M et al.,

microRNA Expression Profiling in Young Prostate Cancer Patients

• Valera VA et al.,

CXXC5 as an unmethylated CpG dinucleotide binding protein contributes to estrogen-mediated cellular proliferation

• Ayaz G et al.,

Biomarkers associated with beneficial PD-1 checkpoint blockade in non-small-cell lung cancer (NSCLC) identified using high-plex digital spatial profiling

• Zugazagoitia J, Gupta S, Liu Y, Fuhrman K, Gettinger S, Herbst RS, Schalper KA, Rimm DL.